Ancora Advisors’s Fortress Biotech FBIO Stock Holding History

Ancora Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,090	Closed	-$129K	–	487
2014 Q4	$113K	Sell	3,090 -6,667	-68%	-$196K	0.01%	472
2014 Q3	$307K	Sell	9,757 -8,000	-45%	-$212K	0.04%	364
2014 Q2	$458K	Buy	17,757 +2,847	+19%	+$75.1K	0.06%	320
2014 Q1	$443K	Sell	14,910 -5,915	-28%	-$231K	0.06%	300
2013 Q4	$822K	Buy	+20,825	New	+$804K	0.12%	196

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Ancora Advisors's FBIO Position: Q1 2015 in Review

Ancora Advisors sold out of Fortress Biotech (FBIO) in Q1 2015, closing a stake of 3,090 shares — an estimated $129K sold.

Ancora Advisors first reported a position in FBIO in Q4 2013 and held it in 5 quarters. The position peaked at $822K in Q4 2013. 49 funds tracked by Wall St. Rank hold FBIO as of Q1 2015.

Ancora Advisors reported no remaining Fortress Biotech position as of Q1 2015 after selling out during the quarter.
Ancora Advisors sold 3,090 Fortress Biotech shares in Q1 2015, an estimated $129K.
Ancora Advisors first reported a position in Fortress Biotech in Q4 2013 and held it in 5 quarters.
Ancora Advisors's Fortress Biotech position peaked at $822K in Q4 2013.
49 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2015.

Based on Ancora Advisors's 13F filing for Q1 2015, filed 15 May 2015.